UChicago Medicine joins BOOST-3 national trial to investigate treatments for traumatic brain injuries
Originally published in The Forefront 9/9/2020 Physicians at the University of Chicago Medicine are participating in a national trial to study the most effective course of treatment for patients with traumatic brain injuries (TBI). The study will involve patients admitted to UChicago Medicine’s Level 1 Adult Trauma Center with injuries caused by motor vehicle collisions, falls or other incidents causing severe trauma to the brain. Every year, approximately 3.5 million Americans sustain a TBI, of which 50,000 die. Another 300,000 are hospitalized, but survive the injury. UChicago Medicine researchers will begin screening and enrolling patients in the study in early … Read More